What is the recommended treatment for syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Syphilis Treatment Recommendations

Benzathine penicillin G is the first-line treatment for all stages of syphilis, with dosage varying based on disease stage. 1

Treatment Regimens by Stage

Early Syphilis (Primary, Secondary, Early Latent < 1 year)

  • First-line: Benzathine penicillin G 2.4 million units IM in a single dose 1
  • Alternative (if penicillin allergic/unavailable):
    • Doxycycline 100 mg orally twice daily for 14 days 1, 2
    • Tetracycline 500 mg orally four times daily for 14 days 1

Late Latent Syphilis or Unknown Duration

  • First-line: Benzathine penicillin G 7.2 million units total, administered as 3 doses of 2.4 million units IM at 1-week intervals 1
  • Alternative: Doxycycline 100 mg orally twice daily for 28 days 1, 2

Neurosyphilis

  • First-line: Penicillin G aqueous 18-24 million units IV daily, administered as 3-4 million units every 4 hours for 10-14 days 1
  • Alternative: Ceftriaxone 1 g IV/IM daily for 10 days 2

Special Populations

HIV-Infected Patients

  • Same regimens as HIV-negative patients but with closer follow-up 1
  • Limited data suggest no benefit to >1 dose of benzathine penicillin G for early syphilis in HIV-infected patients 2

Pregnant Women

  • Penicillin is the only proven effective treatment 1
  • Desensitization is required if allergic to penicillin 1

Alternative Treatments

Doxycycline

  • Acceptable alternative when penicillin cannot be used 2, 3
  • Efficacy data shows comparable outcomes to penicillin for early syphilis 3
  • May have slightly lower success rates for late latent and undetermined syphilis infections 4

Ceftriaxone

  • Reasonable alternative for early syphilis (1 g/day IV/IM for 10 days) 2

Azithromycin

  • Not recommended in the United States due to high prevalence of resistance mutations 2, 1
  • Despite showing efficacy in some settings 5, concerns about resistance make it unsuitable

Follow-up and Monitoring

  • Obtain quantitative non-treponemal test titers (RPR or VDRL) at baseline and follow-up at 6,12, and 24 months 1
  • Successful treatment should show a fourfold decline in titers within:
    • 6 months for primary/secondary syphilis
    • 12-24 months for latent/late syphilis 1

Partner Management

  • Sexual contacts within 90 days of diagnosis should be treated presumptively, even if seronegative 1
  • Contacts from >90 days should be treated presumptively if follow-up is uncertain 1

Common Pitfalls

  1. Inadequate follow-up after treatment 1
  2. Failure to identify and treat sexual contacts 1
  3. Using macrolides empirically despite emerging resistance 1
  4. Medication administration issues - BPG is highly viscous and may result in underdosing if not administered properly 6
  5. Penicillin shortages - Be aware of potential supply issues that may necessitate alternative treatments 7
  6. Misinterpreting treatment failure - Approximately 15% of patients may not meet standard criteria for serological cure 12 months after adequate treatment 1

Benzathine penicillin G remains the gold standard treatment for syphilis across all stages, with specific dosing regimens based on disease stage. Alternative treatments should only be used when penicillin therapy is not feasible.

References

Guideline

Syphilis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Doxycycline compared with benzathine penicillin for the treatment of early syphilis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.